Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $5.99 billion. The enterprise value is $5.98 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 97.03 million shares outstanding. The number of shares has increased by 16.75% in one year.
| Current Share Class | 97.03M |
| Shares Outstanding | 97.03M |
| Shares Change (YoY) | +16.75% |
| Shares Change (QoQ) | +7.99% |
| Owned by Insiders (%) | 4.51% |
| Owned by Institutions (%) | 93.71% |
| Float | 92.55M |
Valuation Ratios
The trailing PE ratio is 26.41 and the forward PE ratio is 9.68. SRPT's PEG ratio is 0.14.
| PE Ratio | 26.41 |
| Forward PE | 9.68 |
| PS Ratio | 3.09 |
| Forward PS | 1.88 |
| PB Ratio | 3.92 |
| P/TBV Ratio | 3.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.14 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 25.42 |
| EV / Sales | 3.14 |
| EV / EBITDA | 23.38 |
| EV / EBIT | 27.42 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.88.
| Current Ratio | 4.20 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 3.74 |
| Debt / FCF | n/a |
| Interest Coverage | 11.86 |
Financial Efficiency
Return on equity (ROE) is 19.71% and return on invested capital (ROIC) is 5.34%.
| Return on Equity (ROE) | 19.71% |
| Return on Assets (ROA) | 3.77% |
| Return on Invested Capital (ROIC) | 5.34% |
| Return on Capital Employed (ROCE) | 6.75% |
| Revenue Per Employee | $1.39M |
| Profits Per Employee | $171,457 |
| Employee Count | 1,372 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.09 |
Taxes
In the past 12 months, SRPT has paid $25.54 million in taxes.
| Income Tax | 25.54M |
| Effective Tax Rate | 9.79% |
Stock Price Statistics
The stock price has decreased by -47.27% in the last 52 weeks. The beta is 0.92, so SRPT's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -47.27% |
| 50-Day Moving Average | 81.59 |
| 200-Day Moving Average | 115.94 |
| Relative Strength Index (RSI) | 44.97 |
| Average Volume (20 Days) | 2,847,127 |
Short Selling Information
The latest short interest is 6.10 million, so 6.29% of the outstanding shares have been sold short.
| Short Interest | 6.10M |
| Short Previous Month | 4.85M |
| Short % of Shares Out | 6.29% |
| Short % of Float | 6.59% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, SRPT had revenue of $1.90 billion and earned $235.24 million in profits. Earnings per share was $2.34.
| Revenue | 1.90B |
| Gross Profit | 778.36M |
| Operating Income | 218.08M |
| Pretax Income | 62.22M |
| Net Income | 235.24M |
| EBITDA | 255.81M |
| EBIT | 218.08M |
| Earnings Per Share (EPS) | $2.34 |
Full Income StatementBalance Sheet
The company has $1.35 billion in cash and $1.34 billion in debt, giving a net cash position of $11.92 million or $0.12 per share.
| Cash & Cash Equivalents | 1.35B |
| Total Debt | 1.34B |
| Net Cash | 11.92M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 15.77 |
| Working Capital | 2.34B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$205.79 million and capital expenditures -$136.96 million, giving a free cash flow of -$342.74 million.
| Operating Cash Flow | -205.79M |
| Capital Expenditures | -136.96M |
| Free Cash Flow | -342.74M |
| FCF Per Share | -$3.53 |
Full Cash Flow StatementMargins
Gross margin is 40.92%, with operating and profit margins of 11.47% and 12.37%.
| Gross Margin | 40.92% |
| Operating Margin | 11.47% |
| Pretax Margin | 13.71% |
| Profit Margin | 12.37% |
| EBITDA Margin | 13.45% |
| EBIT Margin | 11.47% |
| FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.75% |
| Shareholder Yield | -16.75% |
| Earnings Yield | 3.93% |
| FCF Yield | -5.72% |
Dividend DetailsAnalyst Forecast
The average price target for SRPT is $153.50, which is 148.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $153.50 |
| Price Target Difference | 148.54% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 15.35% |
| EPS Growth Forecast (5Y) | 44.74% |
Stock ForecastsStock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 0.1666666:1.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1666666:1 |
Scores
SRPT has an Altman Z-Score of 2.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 5 |